HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$13.99−0.41 (-2.85%)
Close on Nov 18, 2026Market cap $2.44BP/E 5.4Yield –
HUTCHMED (China) operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
HUTCHMED (China)'s operating income for the twelve months ending Dec 31, 2019 was -$146.39M. For fiscal 2025 it was -$39.16M. The highest annual figure on record is $18.38M in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$39.16M | – |
| FY2024 | Dec 31, 2024 | -$43.71M | -337.9% |
| FY2023 | Dec 31, 2023 | $18.38M | – |
| FY2022 | Dec 31, 2022 | -$407.69M | – |
| FY2021 | Dec 31, 2021 | -$328.32M | – |
| FY2020 | Dec 31, 2020 | -$196.67M | – |
| FY2019 | Dec 31, 2019 | -$146.39M | – |
| FY2018 | Dec 31, 2018 | -$92.64M | – |
| FY2017 | Dec 31, 2017 | -$53.42M | – |
| FY2016 | Dec 31, 2016 | -$46.70M | – |
| FY2015 | Dec 31, 2015 | -$9.77M | – |
| FY2014 | Dec 31, 2014 | -$18.26M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | -$38.43M | – |
| Q3 FY2019 | Sep 30, 2019 | -$35.94M | – |
| Q2 FY2019 | Jun 30, 2019 | -$35.96M | – |
| Q1 FY2019 | Mar 31, 2019 | -$36.05M | – |
| Q4 FY2018 | Dec 31, 2018 | -$24.17M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.79M | – |
| Q2 FY2018 | Jun 30, 2018 | -$28.66M | – |
| Q1 FY2018 | Mar 31, 2018 | -$25.02M | – |
See a number that looks wrong?